Boric acid for recurrent vulvovaginal candidiasis: the clinical evidence. [electronic resource]
- Journal of women's health (2002) Aug 2011
- 1245-55 p. digital
Publication Type: Journal Article; Review
1931-843X
10.1089/jwh.2010.2708 doi
Administration, Intravaginal Anti-Infective Agents, Local--administration & dosage Antifungal Agents--therapeutic use Azoles--therapeutic use Biological Availability Boric Acids--administration & dosage Candida--drug effects Candidiasis, Vulvovaginal--drug therapy Case-Control Studies Drug Resistance, Multiple, Fungal Female Flucytosine--therapeutic use Humans Randomized Controlled Trials as Topic Secondary Prevention Suppositories--administration & dosage Treatment Outcome Vaginal Diseases--chemically induced